FDA Medical devices recall ·

FilmArray NGDS Warrior Panel recall

Recall number
Z-2877-2026
Date
(initiated July 16, 2026)
Company / brand
Biofire Defense
79 W 4500 S Ste 14, Salt Lake City, UT, United States
Category
Medical devices › Class II
Classification
Class II
Status
Ongoing
Units affected
122 kits (3,660 pouches)
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

FilmArray NGDS Warrior Panel REF NGDS-ASY-0007 UDI-DI code: (01)00851458005136 The FilmArray NGDS Warrior Panel is a qualitative, multiplexed, nucleic acid-based in vitro diagnostic test intended for use with the FilmArray 2.0 system. The FilmArray NGDS Warrior Panel detects and identifies Bacillus anthracis, Yersinia pestis, Francisella tularensis, Coxiella burnetii, Ebola virus, and Marburg virus nucleic acids directly from human whole blood (EDTA).

Why was it recalled?

Firm has identified mismatches between the outbreak strain and the reference strain used in the development of its qualitative, multiplexed, nucleic acid-based in vitro diagnostic panel test.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Part Number: NGDS-ASY-0007 UDI-DI code: (01)00851458005136 Lot Numbers: 311825D 312025D 313526D 322925D

Distribution

U.S. Nationwide distribution in the states of AL, CA, DC, FL, GA, HI, KY, LA, MA, MD, MN, NC, NH, NV, NY, OH, RI, TN, TX, UT, VA and WA.

States: Alabama California District of Columbia Florida Georgia Hawaii Kentucky Louisiana Massachusetts Maryland Minnesota North Carolina New Hampshire Nevada New York Ohio Rhode Island Tennessee Texas Utah Virginia Washington

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (medical devices), recall Z-2877-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.